Wolverine Trading, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.24 - $0.34 $153 - $217	-639 Reduced 3.77%	16,297 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.18 - $0.3 $3,048 - $5,080	16,936 New	16,936 $4,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $1.82 $12,484 - $22,720	12,484 New	12,484 $13,000
Q2 2021 Aug 06, 2021	SELL	$1.55 - $2.15 $17,389 - $24,120	-11,219 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$1.99 - $2.9 $8,214 - $11,971	-4,128 Reduced 26.9%	11,219 $22,000
Q4 2020 Feb 12, 2021	SELL	$1.88 - $2.84 $861 - $1,300	-458 Reduced 2.9%	15,347 $31,000
Q2 2020 Aug 13, 2020	SELL	$0.7 - $4.16 $1,134 - $6,743	-1,621 Reduced 9.3%	15,805 $60,000
Q1 2020 May 11, 2020	BUY	$0.76 - $1.54 $13,243 - $26,836	17,426 New	17,426 $14,000

10.4K

Ticker NAVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,150,900
Description
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.